Preparation of Small-Molecule Microarrays by trans-Cyclooctene Tetrazine Ligation and Their Application in the High-Throughput Screening of Protein-Protein Interaction Inhibitors of Bromodomains

被引:34
作者
Zhang, Chong-Jing [1 ]
Tan, Chelsea Y. J. [1 ]
Ge, Jingyan [1 ]
Na, Zhenkun [1 ]
Chen, Grace Y. J. [1 ]
Uttamchandani, Mahesh [1 ]
Sun, Hongyan [2 ]
Yao, Shao Q. [1 ]
机构
[1] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore
[2] City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China
基金
英国医学研究理事会;
关键词
bioorthogonal chemistry; epigenetics; inhibitors; protein-protein interactions; small-molecule microarrays; DISCOVERY; PEPTIDE; BINDING; TOOLS;
D O I
10.1002/anie.201307803
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Fast and efficient: A library of trans-cyclooctene (TCO)-modified small molecules were immobilized on tetrazine-functionalized glass slides by using the fastest bioorthogonal reaction known. The resulting small-molecule microarray was screened against a variety of human bromodomains to identify protein-protein interaction inhibitors. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:14060 / 14064
页数:5
相关论文
共 39 条
[1]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[2]   Epigenetic protein families: a new frontier for drug discovery [J].
Arrowsmith, Cheryl H. ;
Bountra, Chas ;
Fish, Paul V. ;
Lee, Kevin ;
Schapira, Matthieu .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (05) :384-400
[3]   Preparation of Carbohydrate Arrays by Using Diels-Alder Reactions with Inverse Electron Demand [J].
Beckmann, Henning S. G. ;
Niederwieser, Andrea ;
Wiessler, Manfred ;
Wittmann, Valentin .
CHEMISTRY-A EUROPEAN JOURNAL, 2012, 18 (21) :6548-6554
[4]   BET domain co-regulators in obesity, inflammation and cancer [J].
Belkina, Anna C. ;
Denis, Gerald V. .
NATURE REVIEWS CANCER, 2012, 12 (07) :465-477
[5]   The complex language of chromatin regulation during transcription [J].
Berger, Shelley L. .
NATURE, 2007, 447 (7143) :407-412
[6]  
Chung C., 2012, DRUG DISCOV TODAY, V9, pe111, DOI DOI 10.1016/J.DDSTR.2011.12.002
[7]   Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery [J].
Chung, Chun-wa ;
Dean, Anthony W. ;
Woolven, James M. ;
Bamborough, Paul .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) :576-586
[8]   Progress in the Discovery of Small-Molecule Inhibitors of Bromodomain-Histone Interactions [J].
Chung, Chun-Wa ;
Witherington, Jason .
JOURNAL OF BIOMOLECULAR SCREENING, 2011, 16 (10) :1170-1185
[9]   BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc [J].
Delmore, Jake E. ;
Issa, Ghayas C. ;
Lemieux, Madeleine E. ;
Rahl, Peter B. ;
Shi, Junwei ;
Jacobs, Hannah M. ;
Kastritis, Efstathios ;
Gilpatrick, Timothy ;
Paranal, Ronald M. ;
Qi, Jun ;
Chesi, Marta ;
Schinzel, Anna C. ;
McKeown, Michael R. ;
Heffernan, Timothy P. ;
Vakoc, Christopher R. ;
Bergsagel, P. Leif ;
Ghobrial, Irene M. ;
Richardson, Paul G. ;
Young, Richard A. ;
Hahn, William C. ;
Anderson, Kenneth C. ;
Kung, Andrew L. ;
Bradner, James E. ;
Mitsiades, Constantine S. .
CELL, 2011, 146 (06) :903-916
[10]  
Devaraj N. K., 2009, Angew. Chem, V121, P7147, DOI [10.1002/ange.200903233, DOI 10.1002/ANGE.200903233]